MDxHealth S.A. MDXH 深 沪
等待开盘 05-14 09:30:00 美东时间
1.95
+0.080
+4.28%
华盛通- 最 高2.11
- 今 开1.87
- 成交量 219.21万股
- 最 低 1.8666
- 昨 收 1.87
- 总市值 10.02万
- 52周最高 5.33
- 市盈率 静 --
- 换手率 4267.82%
- 52周最低 1.82
- 委 比 -83.61%
- 总股本 5.14万
- 历史最高 131.70
- 量 比 13.06
- 振 幅 13.02%
- 历史最低 1.35
- 每 手 1
- 风险率 0.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多电话会总结 ｜ MDxHealth(MDXH)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据MDxHealth业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 报告营收：2740万美元（包含已停止的Resolve UTI业务） - 前瞻性营收（核心前列腺癌业务）：2390万美元，同比增长11% **盈利能力：** - 前瞻性毛利润：1500万美元 - 前瞻性毛利率：62.9% - 前瞻性经营亏损：790万美元 - 前瞻性净亏损：940万美元 **现金状况：** - 季度末现金及现金等价物：4320万美元 - 扣除收购款项后调整现金：2820万美元（扣除向Exact Sciences支付的1500万美元收
今天 12:01
美股夜盘 | Linkers Industries Limited Class A涨31.85%，IP Strategy Holdings, Inc.涨24.83%
MDxHealth S.A.涨-45.13%；沃氪医疗涨-26.81%；Motorsport Games, Inc. Class A涨-21.70%
今天 08:05
MDxHealth Reports Q1 2026 Results: Full Earnings Call Transcript
On Wednesday, MDxHealth (NASDAQ:MDXH) discussed first-quarter financial results...
今天 05:08
MDxHealth shares are trading lower after the company reported worse-than-expected Q1 financial results and cut its FY26 sales guidance below estimates.
MDxHealth shares are trading lower after the company reported worse-than-expect...
今天 04:48
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
Mdxhealth presented findings from the GPS-ProMPT study at the 2026 EAU Congress, demonstrating that its Genomic Prostate Score (GPS mdx) test predicts adverse outcomes across various prostate cancer treatments. Led by Professor Freddie Hamdy of Oxford University, the study analyzed 409 patients over six years and found that GPS mdx accurately stratified treatment failure risks, supporting personalized care decisions. The test successfully identif...
03-16 20:00
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Mdxhealth Advances University Of Oxford Collaboration With GPS Testing In UK ProtecT Trial, Targeting First Genomic Classifier Evidence
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancerIRVINE, CA – January XX, 2026 (GlobeNewswire) – Mdxhealth SA
01-06 21:03
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
Mdxhealth与牛津大学合作启动Genomic Prostate Score (GPS)测试在ProtecT试验中的验证工作。ProtecT试验是全球最大的局部前列腺癌治疗效果随机试验，跟踪1500多名患者20余年，提供长期数据。该研究将评估GPS在主动监测队列中的临床效用，利用ProtecT试验的长期数据进一步验证GPS预测前列腺癌进展和治疗结果的能力。Mdxhealth CEO Michael K. McGarrity称这一合作标志着前列腺癌精准诊断的重要转折点，而牛津大学教授Hamdy则表示，通过整合基因组见解，研究可能重新定义全球医生的风险评估和患者护理方式。
01-06 13:00
BRIEF-MDxHealth SA - To Offer Securities Up To $200 Million - SEC Filing
Dec 29 (Reuters) - MDxHealth SA MDXH.O: MDXHEALTH SA - TO OFFER SECURITIES UP TO $200 MILLION - SEC FILING Source text: [ID:n0001213900-25-126084] Further company coverage: MDXH.O ((Reuters.Briefs@tho...
2025-12-30 06:48
